Bénédicte Menn

Inversor de Capital Privado en

Oxford University Innovation Ltd.

Consumer Services

Finance

Health Technology

Perfil

Bénédicte Menn founded Neurokin SA in 2003, where she worked as Project Leader from 2009 to 2014.
Dr. Menn also currently works at Oxford University Innovation Ltd., as Senior Investment Manager.
Dr. Menn received her undergraduate degree in 1990 from Ecole Nationale d'Administration.

Cargos activos de Bénédicte Menn

Empresas	Cargo	Inicio
Oxford University Innovation Ltd. Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements.	Inversor de Capital Privado	01/01/2017

Todos los cargos activos de Bénédicte Menn

Antiguos cargos conocidos de Bénédicte Menn.

Empresas	Cargo	Fin
Neurokin SA Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy	Fundador	11/03/2014

Ver el detalle de la experiencia de Bénédicte Menn.

Formación de Bénédicte Menn.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Bénédicte Menn.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Ecole Nationale d'Administration Ecole Nationale d'Administration Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oxford University Innovation Ltd. Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements.	Finance
Neurokin SA Neurokin SA BiotechnologyHealth Technology Develops kinase inhibitors for the treatment and prevention of neurological diseases like stroke and epilepsy	Health Technology